Brief: TScan Therapeutics Expects $2.3 Million One-Time Charge For Severance During 3 Months Ended Dec 31
03/11/2025 11:38
Nov 3 (Reuters) - TScan Therapeutics Inc TCRX.O: TSCAN THERAPEUTICS INC - EXPECTS $2.3 MILLION ONE-TIME CHARGE FOR SEVERANCE DURING 3 MONTHS ENDED DEC 31 - SEC FILING Source text: [ID:n0001193125-25-261612] Further company coverage: TCRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tscan Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Broadcom, Deere & Co, Snowflake
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing